Highlights and Quick Summary
- Net Current Asset Value for the quarter ending March 31, 2023 was $3.89 Million (a -51.79% decrease compared to previous quarter)
- Year-over-year quarterly Net Current Asset Value increased by 124.87%
- Annual Net Current Asset Value for 2022 was $1.73 Million (a 0.0% decrease from previous year)
- Annual Net Current Asset Value for 2022 was $1.73 Million (a -91.01% decrease from previous year)
- Annual Net Current Asset Value for 2021 was $19.2 Million (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Current Asset Value of Benitec Biopharma Limited
Most recent Net Current Asset Valueof BNTC including historical data for past 10 years.Interactive Chart of Net Current Asset Value of Benitec Biopharma Limited
Benitec Biopharma Limited Net Current Asset Value for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $3.89 | – | – | – | – |
2022 | $8.06 | $13.58 | $1.73 | $6.3 | $1.73 |
2021 | $9.49 | $14.01 | $19.24 | $9.91 | $19.24 |
2020 | $13.5 | $6.88 | $9.46 | $11.48 | $9.46 |
2019 | – | – | – | $13.94 | $16.12 |
2018 | – | – | – | – | $14.19 |
2017 | – | – | – | $14.44 | $15.83 |
2016 | – | $14.59 | $13.35 | $17.51 | $13.35 |
2015 | – | – | $19.3 | $19.61 | $19.61 |
2014 | – | – | $24.99 | $30.76 | $30.76 |
2013 | $0.62 | – | – | – | $0.63 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology